264 related articles for article (PubMed ID: 34766392)
1. Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD.
Zagari RM; Romano M; Frazzoni L; Marasco G; Dajti E; Arcidiacono PG; Armuzzi A; Biagi F; Cannizzaro R; Cavestro GM; Ciacci C; Monica F; Peralta S; Radaelli F; Bazzoli F
Helicobacter; 2022 Feb; 27(1):e12862. PubMed ID: 34766392
[TBL] [Abstract][Full Text] [Related]
2. Real-world practice of Helicobacter pylori management: A survey among physicians in Southeast Asia.
Quach DT; Vilaichone RK; Luu MN; Lee YY; Ang TL; Miftahussurur M; Aye TT; Basir DN; Vutha K; Vannarath S; Sollano JD; Mahachai V
Helicobacter; 2023 Dec; 28(6):e13018. PubMed ID: 37634226
[TBL] [Abstract][Full Text] [Related]
3. Low Adherence to Society Guidelines for the Management of Helicobacter Pylori Among Pediatric Gastroenterologists.
Bonilla S; Mitchell PD; Mansuri I
J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):178-183. PubMed ID: 34402809
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals: A stratified sampling cross-sectional survey.
Zhang WL; Li YY; Liu J; Wang J; Wan M; Lin BS; Lin MJ; Ding YM; Kong QZ; Wang ST; Duan M; Han ZX; Ji R; Zuo XL; Li YQ
J Dig Dis; 2022 Jul; 23(7):365-375. PubMed ID: 35880374
[TBL] [Abstract][Full Text] [Related]
5. [Helicobacter pylori-associated diseases].
Gisbert JP
Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
[TBL] [Abstract][Full Text] [Related]
6. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
7. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Maastricht V/Florence consensus report for the management of Helicobacter pylori infection among primary care physicians and medical students in Croatia: A cross-sectional study.
Jukic I; Vukovic J; Rusic D; Bozic J; Bukic J; Leskur D; Seselja Perisin A; Modun D
Helicobacter; 2021 Apr; 26(2):e12775. PubMed ID: 33368852
[TBL] [Abstract][Full Text] [Related]
9. [European registry on Helicobacter pylori management (Hp-EuReg) as a tool to evaluate and improve clinical practice in Moscow].
Bordin DS; Voynovan IN; Embutnieks YV; Nyssen OP; Megraud F; O Morain C; Perez-Gisbert J
Ter Arkh; 2020 Apr; 92(2):12-18. PubMed ID: 32598712
[TBL] [Abstract][Full Text] [Related]
10. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
Zhou Y; Ye Z; Wang Y; Zhang Y; Tang Z; Yan W; Jiang Y; Huang Y
Helicobacter; 2020 Apr; 25(2):e12679. PubMed ID: 31958193
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Zagari RM; Romano M; Ojetti V; Stockbrugger R; Gullini S; Annibale B; Farinati F; Ierardi E; Maconi G; Rugge M; Calabrese C; Di Mario F; Luzza F; Pretolani S; Savio A; Gasbarrini G; Caselli M
Dig Liver Dis; 2015 Nov; 47(11):903-12. PubMed ID: 26253555
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for
Zhang YW; Hu WL; Cai Y; Zheng WF; Du Q; Kim JJ; Kao JY; Dai N; Si JM
World J Gastroenterol; 2018 Oct; 24(40):4596-4605. PubMed ID: 30386109
[TBL] [Abstract][Full Text] [Related]
14. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.
Kato S; Shimizu T; Toyoda S; Gold BD; Ida S; Ishige T; Fujimura S; Kamiya S; Konno M; Kuwabara K; Ushijima K; Yoshimura N; Nakayama Y;
Pediatr Int; 2020 Dec; 62(12):1315-1331. PubMed ID: 32657507
[TBL] [Abstract][Full Text] [Related]
15. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Luther J; Higgins PD; Schoenfeld PS; Moayyedi P; Vakil N; Chey WD
Am J Gastroenterol; 2010 Jan; 105(1):65-73. PubMed ID: 19755966
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
[TBL] [Abstract][Full Text] [Related]
17. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
Xie Y; Zhu Z; Wang J; Zhang L; Zhang Z; Lu H; Zeng Z; Chen S; Liu D; Lv N;
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914954
[TBL] [Abstract][Full Text] [Related]
18. [European Registry on the management of Helicobacter pylori infection: features of diagnosis and treatment in Kazan].
Abdulkhakov SR; Bordin DS; Abdulkhakov RA; Safina DD; Gizdatullina AR; Gimadieva LZ; Safina GM; Ziyatdinov AI; Maturina AM; Nyssen OP; Megraud F; O'Morain C; Perez-Gisbert J
Ter Arkh; 2020 Sep; 92(8):52-59. PubMed ID: 33346462
[TBL] [Abstract][Full Text] [Related]
19. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
20. Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
Gisbert JP; Perez-Aisa A; Rodrigo L; Molina-Infante J; Modolell I; Bermejo F; Castro-Fernández M; Antón R; Sacristán B; Cosme A; Barrio J; Harb Y; Gonzalez-Barcenas M; Fernandez-Bermejo M; Algaba A; Marín AC; McNicholl AG;
Dig Dis Sci; 2014 Feb; 59(2):383-9. PubMed ID: 24126798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
